{"pmid":32463538,"title":"Excess out-of-hospital deaths during COVID-19 outbreak: evidence of pulmonary embolism as a main determinant.","text":["Excess out-of-hospital deaths during COVID-19 outbreak: evidence of pulmonary embolism as a main determinant.","Eur J Heart Fail","Benzakoun, Joseph","Hmeydia, Ghazi","Delabarde, Tania","Hamza, Lilia","Meder, Jean-Francois","Ludes, Bertrand","Mebazaa, Alexandre","32463538"],"journal":"Eur J Heart Fail","authors":["Benzakoun, Joseph","Hmeydia, Ghazi","Delabarde, Tania","Hamza, Lilia","Meder, Jean-Francois","Ludes, Bertrand","Mebazaa, Alexandre"],"date":"2020-05-29T11:00:00Z","year":2020,"_id":"32463538","source":"PubMed","week":"202022|May 25 - May 31","doi":"10.1002/ejhf.1916","keywords":["covid-19","deep venous thrombosis","pandemic","post-mortem imaging","pulmonary embolism"],"topics":["Prevention"],"weight":1,"_version_":1668079521295761408,"score":9.490897,"similar":[{"pmid":32305585,"pmcid":"PMC7162794","title":"Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 Pandemic.","text":["Practical diagnosis and treatment of suspected venous thromboembolism during COVID-19 Pandemic.","A markedly increased demand for vascular ultrasound laboratory and other imaging studies in COVID-19 positive patients has occurred, due to most with markedly elevated D-dimer, and a presumed prothrombotic state in many of the very ill patients. This article summarizes a broad institutional consensus focusing on evaluation and recommended empirical therapy for COVID-19 positive patients. We recommend following the algorithms with the idea that as more data becomes available that this may well change.","J Vasc Surg Venous Lymphat Disord","Obi, Andrea T","Barnes, Geoff D","Wakefield, Thomas W","Brown Rvt, Sandra","Eliason, Jonathon L","Arndt, Erika","Henke, Peter K","32305585"],"abstract":["A markedly increased demand for vascular ultrasound laboratory and other imaging studies in COVID-19 positive patients has occurred, due to most with markedly elevated D-dimer, and a presumed prothrombotic state in many of the very ill patients. This article summarizes a broad institutional consensus focusing on evaluation and recommended empirical therapy for COVID-19 positive patients. We recommend following the algorithms with the idea that as more data becomes available that this may well change."],"journal":"J Vasc Surg Venous Lymphat Disord","authors":["Obi, Andrea T","Barnes, Geoff D","Wakefield, Thomas W","Brown Rvt, Sandra","Eliason, Jonathon L","Arndt, Erika","Henke, Peter K"],"date":"2020-04-20T11:00:00Z","year":2020,"_id":"32305585","source":"PubMed","week":"202017|Apr 20 - Apr 26","doi":"10.1016/j.jvsv.2020.04.009","keywords":["anticoagulant","deep venous thrombosis","duplex ultrasound","pulmonary embolism","venous thromboembolism"],"topics":["Treatment","Diagnosis"],"weight":1,"_version_":1666138493389111296,"score":95.869156},{"pmid":32394237,"title":"Sudden death due to acute pulmonary embolism in a young woman with COVID-19.","text":["Sudden death due to acute pulmonary embolism in a young woman with COVID-19.","Coronavirus disease 2019 (COVID-19) is an infectious disease that primarily affects the respiratory system, but it may cause cardiovascular complications such as thromboembolism. Rarely, pulmonary embolism may be encountered in patients with severe COVID-19 infection, especially in intensive care units. An asymptomatic young case of COVID-19 presenting with sudden death due to acute massive pulmonary embolism has not been previously described. We report a 41-year-old woman presented to emergency department with sudden death during physical activity. She had only history of diabetes mellitus and she was asymptomatic until sudden death. CT pulmonary angiography and chest CT scans revealed acute massive embolism and typical imaging findings of COVID-19 pneumonia, respectively. Interestingly, the patient had no symptoms or signs of infection and also had no risk factors for thromboembolism. COVID-19 infection appears to induce venous thromboembolism, especially pulmonary embolism. The case is remarkable in terms of showing how insidious and life-threatening COVID-19 infection can be.","J Thromb Thrombolysis","Polat, Veli","Bostanci, Gungor Ilayda","32394237"],"abstract":["Coronavirus disease 2019 (COVID-19) is an infectious disease that primarily affects the respiratory system, but it may cause cardiovascular complications such as thromboembolism. Rarely, pulmonary embolism may be encountered in patients with severe COVID-19 infection, especially in intensive care units. An asymptomatic young case of COVID-19 presenting with sudden death due to acute massive pulmonary embolism has not been previously described. We report a 41-year-old woman presented to emergency department with sudden death during physical activity. She had only history of diabetes mellitus and she was asymptomatic until sudden death. CT pulmonary angiography and chest CT scans revealed acute massive embolism and typical imaging findings of COVID-19 pneumonia, respectively. Interestingly, the patient had no symptoms or signs of infection and also had no risk factors for thromboembolism. COVID-19 infection appears to induce venous thromboembolism, especially pulmonary embolism. The case is remarkable in terms of showing how insidious and life-threatening COVID-19 infection can be."],"journal":"J Thromb Thrombolysis","authors":["Polat, Veli","Bostanci, Gungor Ilayda"],"date":"2020-05-13T11:00:00Z","year":2020,"_id":"32394237","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1007/s11239-020-02132-5","keywords":["covid-19","case report","pulmonary embolism","sudden death"],"topics":["Case Report"],"weight":1,"_version_":1666627827877806081,"score":83.20834},{"pmid":32444371,"title":"COVID-19 and pulmonary embolism: diagnostic imaging trends.","text":["COVID-19 and pulmonary embolism: diagnostic imaging trends.","J Nucl Med","Karimzadeh, Sedighe","Raut, Akshay","Nguyen Tien, Huy","32444371"],"journal":"J Nucl Med","authors":["Karimzadeh, Sedighe","Raut, Akshay","Nguyen Tien, Huy"],"date":"2020-05-24T11:00:00Z","year":2020,"_id":"32444371","source":"PubMed","week":"202021|May 18 - May 24","doi":"10.2967/jnumed.120.248518","keywords":["covid-19","cardiology (clinical)","infectious disease","vascular","imaging","pulmonary embolism"],"topics":["Diagnosis"],"weight":1,"_version_":1667600475796537344,"score":73.07695},{"pmid":32474757,"title":"Acute pulmonary embolism in COVID-19 related hypercoagulability.","text":["Acute pulmonary embolism in COVID-19 related hypercoagulability.","Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory failure. This clinical entity seems to be associated with a marked hypercoagulable state that causes both arterial and venous thromboembolic complications. Therefore, an adequate anti-thrombotic prophylaxis is recommended in hospitalized COVID-19 patients. Although rapidly worsening respiratory symptoms in a patient with SARS-CoV-2 respiratory infection may correlate with worsening pneumonia itself, it may also mask a pulmonary embolism. We report the case of a 50-year-old man affected by SARS-CoV-2 pneumonia, who developed acute pulmonary embolism.","J Thromb Thrombolysis","Lorenzo, Cerruti","Francesca, Boscaro","Francesco, Poletto","Elena, Campello","Luca, Spiezia","Paolo, Simioni","32474757"],"abstract":["Since December 2019, a novel Coronavirus (SARS-CoV-2) was confirmed as the etiologic agent of a worldwide outbreak of a pneumonia that can result in severe respiratory failure. This clinical entity seems to be associated with a marked hypercoagulable state that causes both arterial and venous thromboembolic complications. Therefore, an adequate anti-thrombotic prophylaxis is recommended in hospitalized COVID-19 patients. Although rapidly worsening respiratory symptoms in a patient with SARS-CoV-2 respiratory infection may correlate with worsening pneumonia itself, it may also mask a pulmonary embolism. We report the case of a 50-year-old man affected by SARS-CoV-2 pneumonia, who developed acute pulmonary embolism."],"journal":"J Thromb Thrombolysis","authors":["Lorenzo, Cerruti","Francesca, Boscaro","Francesco, Poletto","Elena, Campello","Luca, Spiezia","Paolo, Simioni"],"date":"2020-06-01T11:00:00Z","year":2020,"_id":"32474757","source":"PubMed","week":"202023|Jun 01 - Jun 07","doi":"10.1007/s11239-020-02160-1","keywords":["covid-19","case report","coagulation","interstitial pneumonia","pulmonary embolism","sars-cov-2"],"topics":["Case Report"],"weight":1,"_version_":1668341932617629696,"score":73.07695},{"pmid":32405161,"pmcid":"PMC7219417","title":"D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","text":["D-dimer in patients infected with COVID-19 and suspected pulmonary embolism.","Objective: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. Methods: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. Results: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. Conclusion: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE.","Respir Med","Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Capa, Jorge Abad","Rosell, Antoni","32405161"],"abstract":["Objective: To analyze the risk factors for pulmonary embolism (PE) in patients infected with COVID-19. Methods: We conducted an observational, retrospective study. Patients with severe infection with COVID-19 and suspected PE were included. Results: Patients with higher levels of D-dimer and those requiring intubation were at a higher risk of developing PE. Higher D-dimer levels were associated with a greater probability of PE 3, 6, 9 and 12 days after determining D-dimer levels with an OR of 1.7, 2.0, 2.4 and 2.4, respectively. Conclusion: In conclusion, patients infected with COVID-19 requiring OTI with higher levels of D-dimer have an increased risk of developing PE."],"journal":"Respir Med","authors":["Garcia-Olive, Ignasi","Sintes, Helena","Radua, Joaquim","Capa, Jorge Abad","Rosell, Antoni"],"date":"2020-05-15T11:00:00Z","year":2020,"_id":"32405161","source":"PubMed","week":"202020|May 11 - May 17","doi":"10.1016/j.rmed.2020.106023","keywords":["covid-19","d-dimer","pulmonary embolism"],"topics":["Diagnosis","Treatment"],"weight":1,"_version_":1666802845509222400,"score":71.0246}]}